U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07255755) titled 'Cereboost (American Ginseng Extract) and Brain Function' on Nov. 14.
Brief Summary: The study will assess the immediate, short-term benefits of a single dose of a supplement containing 200mg of Panax quinquefolius (American Ginseng) on cognition (brain function) in healthy young adults.
To understand the effect this product may have, the participants will complete a series of questionnaires and cognitive tests (tests of memory and brain function) at set intervals across a 6-hour period. Blood samples will also be collected to assess the impact of the study product on the participants.
Study Start Date: Nov., 2025
Study Type: INTER...